PR Newswire
BEIJING, Feb. 12, 2018
BEIJING, Feb. 12, 2018 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and other health and well-being focused plant-based products in China, today announced its financial results for the second quarter ended December 31, 2017.
Mr. Yuying Zhang, Chairman and Chief Executive Officer of Shineco, commented, "We are proud of all that we have accomplished in the first two quarters of our fiscal year and are pleased to report the second quarter of 2018 financial results with a 26.3% increase in net income as compared to the second quarter of 2017. We believe that our investment in our Apocynum Industrial Park and Institute of Chinese Apocynum Industrial Technology Research continues to strengthen the long-term outlook of Shineco as a positive long-term investment. In the short term we have seen tremendous growth in our Luobuma product line and are pleased that we have grown to become a high margin business, with revenues grown 327% compared to the second quarter ended December 31, 2016, and have achieved impressive results following our expansion over this past year. The past six months have been immensely positive for Shineco and we are excited to tackle the challenges and opportunities that the next six months will bring, as we anticipate continued future growth in our revenues and net income."
Second Quarter of 2018 Financial Highlights
| | For the Three Months Ended December 31 | ||||
($ millions, except per share data) | | 2017 | | 2016 | | % Change |
Revenue | | 14.13 | | 11.22 | | 25.9% |
Luobuma products | | 3.89 | | 0.91 | | 327.0% |
Chinese medicinal herbal products | | 3.66 | | 3.50 | | 4.8% |
Other agricultural products | | 6.58 | | 6.82 | | -3.4% |
Gross profit | | 4.82 | | 3.95 | | 21.9% |
Gross margin | | 34.1% | | 35.2% | | -1.1% |
Operating income | | 3.24 | | 2.53 | | 28.2% |
Operating margin | | 22.9% | | 22.5% | | 0.4% |
Net income attributable to Shineco | | 3.60 | | 2.85 | | 26.3% |
EPS | | 0.17 | | 0.14 | | 26.3% |
Second Quarter of 2018 Financial Results
Revenues
Revenues for the three months ended December 31, 2017 increased by $2.91 million, or 25.9%, to $14.13 million from $11.22 million for the same period of last year, mainly due to increases in sales from Luobuma products and Chinese medicinal herbal products and partially offset by decreased sales from other agricultural products.
| | For the Three Months Ended December 31 | ||||||||||
| | 2017 | | 2016 | ||||||||
($ millions) | | Revenues | | COGS | | Gross | | Revenues | | COGS | | Gross |
Luobuma products | | 3.89 | | 1.87 | | 51.7% | | 0.91 | | 0.44 | | 51.0% |
Chinese medicinal herbal products | | 3.66 | | 2.75 | | 24.6% | | 3.50 | | 2.48 | | 29.1% |
Other agricultural products | | 6.58 | | 4.67 | | 29.0% | | 6.82 | | 4.33 | | 36.4% |
Business and sales related taxes | | - | | 0.03 | | - | | - | | 0.02 | | - |
Total | | 14.13 | | 9.31 | | 34.1% | | 11.22 | | 7.27 | | 35.2% |
Revenues from Luobuma products increased by $2.98 million, or 327.0%, to $3.89 million for the three months ended December 31, 2017 from $0.91 million for the same period of last year, mainly due to establishment of new subsidiary, Xinjiang Taihe, which generated revenue of $2.93 million.
Revenues from Chinese medicinal herbal products increased by $0.17 million, or 4.8%, to $3.66 million for the three months ended December 31, 2017 from $3.50 million for the same period of last year. The increase was primarily due to more fulfilled sales orders from customers for the three months ended December 31, 2017 than the same period in 2016.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.